CML HealthCare Income Fund Reports 2009 Third Quarter Financial Results
CML HealthCare Income Fund Announces Release Date for Fiscal 2009 Third Quarter Financial Results
To keep up to date with news from this category use our
CML HealthCare Income Fund Announces Release Date for Fiscal 2009 Third Quarter Financial Results
MISSISSAUGA, ON, Nov. 4 - CML HealthCare Income Fund (TSX: CLC.UN), will release its 2009 third quarter financial results via www.newswire.ca prior to markets opening on November 11th , 2009. Following the release, CML...
ORTHO CLINICAL DIAGNOSTICS LAUNCHES FETALSCREEN(TM) II FETAL MATERNAL HEMORRHAGE SCREENING TEST
RARITAN, N.J. (Oct. 23, 2009) - Ortho Clinical Diagnostics announced the launch of FETALSCREEN(TM) II Fetal Maternal Hemorrhage Screening Test, a simple, qualitative test that detects D (Rho) positive fetal red blood...
Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems
MADISON, N.J., June 22, 2009 -- HemoCue Inc., the U.S. point-of-care testing distribution subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that it has signed an agreement with Medical Automation...
University of Southern California receives $1 million NIH grant to study TXA127 for the prevention of radiation damage
Brookline, MA, October 7,2008 -- Tarix Phamaceuticals today announced that the University of Southern California has received a grant to study the effects of TXA127 in preventing thrombocytopenia following radiation...
Tarix Pharmaceuticals receives FDA approval for Phase 2 study to mitigate chemotherapy-induced thrombocytopenia
Brookline,MA , June 25, 2008 -- Tarix Phamaceuticals announced that it has received FDA approval to begin a Phase II clinical trial of TXA127 for the prevention of chemotherapy induced thrombocytopenia. The trial will...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
